Nasdaq · CIK 0001001316
TGTX TG THERAPEUTICS, INC.
Insider trading from SEC Form 4. Last filing 29 d ago. Close $55.37 on Oct 9, 2026, +106% from the 52-week low and -6% from the high.
Last 90 days
Net insider value
-$275k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$275k by 1 insider
Insiders on file
7
with a Form 4 at this company
Price and insider trades, last year
TGTXOct 9, 2026 · close 55.37
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at TG THERAPEUTICS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Laurence N Charney director sell | $275k 5,000 shares | -3% | - | |
| 26Weak | Yann Echelard director sell | $163k 5,000 shares | -2% | +21% from low-30% from high | |
| 40Moderate | Sagar Lonial director sell | $672k 20,852 shares | -18% | +52% from low-29% from high | |
| 30Weak | Yann Echelard director sell | $369k 10,000 shares | -4% | +69% from low-21% from high | |
| 57Moderate | Laurence N Charney director sell | $755k 25,000 shares | -11% | - | |
| 41Moderate | Sagar Lonial director sell | $152k 5,000 shares | -5% | - | |
| 48Moderate | Yann Echelard director sell | $490k 20,000 shares | -8% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 13, 2025 | Echelard Yann Director | 10,000 0.01% of outstanding | $369k | Jun 13, 2025 | none |
| Jan 6, 2025 | Power Sean A Officer | 10,021 0.01% of outstanding | $286k | Jan 6, 2025 | $343k |
| Jan 3, 2025 | Power Sean A Officer | 11,337 0.01% of outstanding | $343k | Jan 3, 2025 | none |
| Nov 12, 2024 | Charney Laurence N Director | 25,000 0.02% of outstanding | $755k | Nov 11, 2024 | none |
| Nov 12, 2024 | Lonial Sagar Director | 5,000 0.00% of outstanding | $152k | Nov 11, 2024 | none |
| Nov 5, 2024 | Echelard Yann Director | 20,000 0.01% of outstanding | $490k | Nov 5, 2024 | none |
Transactions
The last 22 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Laurence N Charney director | SOpen-market sale Common Stock | -5,000 | $54.96 | $275k | 168,640 | 29 d ago |
| Jun 11, 2026 | Laurence N Charney director | AGrant or award Stock Tracking Unitderivative | +8,325 | $0.00 | $0 | 8,325 | Jun 15, 2026 |
| Jan 28, 2026 | Laurence N Charney director | GGift Common Stock | -30,000 | $0.00 | $0 | 192,887 | Jan 29, 2026 |
| Jan 29, 2026 | Laurence N Charney director | GGift Common Stock | -13,197 | $0.00 | $0 | 179,690 | Jan 29, 2026 |
| Jan 8, 2026 | Sean A Power CFO | AGrant or award Common Stock | +90,000 | $0.00 | $0 | 798,111 | Jan 9, 2026 |
| Jan 8, 2026 | Michael S Weiss CEO | AGrant or award Common Stock | +622,000 | $0.00 | $0 | 9,778,086 | Jan 9, 2026 |
| Nov 24, 2025 | Yann Echelard director | SOpen-market sale Common Stock | -5,000 | $32.57 | $163k | 223,816 | Nov 25, 2025 |
| Nov 5, 2025 | Michael S Weiss CEO | GGift Common Stock | -3,865,126 | $0.00 | $0 | 9,959,803 | Nov 7, 2025 |
| Nov 5, 2025 | Michael S Weiss CEO | GGift Common Stock | -803,717 | $0.00 | $0 | 9,156,086 | Nov 7, 2025 |
| Sep 11, 2025 | Sagar Lonial director | SOpen-market sale Common Stock | -20,852 | $32.24 | $672k | 94,061 | Sep 12, 2025 |
| Jun 12, 2025 | Laurence N Charney director | AGrant or award Common Stock | +21,408 | $0.00 | $0 | 222,887 | Jun 16, 2025 |
| Jun 12, 2025 | Sagar Lonial director | AGrant or award Common Stock | +14,718 | $0.00 | $0 | 114,913 | Jun 16, 2025 |
| Jun 12, 2025 | Kenneth Hoberman director | AGrant or award Common Stock | +14,718 | $0.00 | $0 | 279,653 | Jun 16, 2025 |
| Jun 12, 2025 | Daniel Hume director | AGrant or award Common Stock | +14,718 | $0.00 | $0 | 192,748 | Jun 16, 2025 |
| Jun 12, 2025 | Yann Echelard director | AGrant or award Common Stock | +14,718 | $0.00 | $0 | 238,816 | Jun 16, 2025 |
| Jun 13, 2025 | Yann Echelard director | SOpen-market sale Common Stock | -10,000 | $36.94 | $369k | 228,816 | Jun 16, 2025 |
| Mar 17, 2025 | Daniel Hume director | GGift Common Stock | -62,459 | $0.00 | $0 | 178,030 | Mar 18, 2025 |
| Mar 10, 2025 | Laurence N Charney director | GGift Common Stock | -6,000 | $0.00 | $0 | 201,479 | Mar 11, 2025 |
| Nov 11, 2024 | Laurence N Charney director | SOpen-market sale Common Stock | -25,000 | $30.20 | $755k | 212,479 | Nov 12, 2024 |
| Nov 11, 2024 | Sagar Lonial director | SOpen-market sale Common Stock | -5,000 | $30.44 | $152k | 100,195 | Nov 12, 2024 |
| Nov 12, 2024 | Laurence N Charney director | GGift Common Stock | -5,000 | $0.00 | $0 | 207,479 | Nov 12, 2024 |
| Nov 5, 2024 | Yann Echelard director | SOpen-market sale Common Stock | -20,000 | $24.48 | $490k | 224,098 | Nov 7, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Laurence N Charneydirector
- Yann Echelarddirector
- Daniel Humedirector
- Kenneth Hobermandirector
- Sagar Lonialdirector
- Sean A PowerCFO
- Michael S WeissCEO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.